Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Tomokazu Matsusue"'
Autor:
Takaho Terada, Alexander A. Tokmakov, Takako Fujimoto, Mutsuko Kukimoto-Niino, Masaki Kawamoto, Tomokazu Matsusue, Mikako Shirouzu, Ikuya Shiromizu, Shigeyuki Yokoyama, Naomi Ohbayashi, Sumiko Gomi
Publikováno v:
Acta Crystallographica Section D Biological Crystallography. 67:763-773
The mitochondrial pyruvate dehydrogenase complex (PDC) catalyzes the oxidative decarboxylation of pyruvate to acetyl-CoA. PDC activity is tightly regulated by four members of a family of pyruvate dehydrogenase kinase isoforms (PDK1-4), which phosphor
Autor:
Fumihiko Saitoh, Hidemitsu Nishida, Yoshitaka Hosaka, Munetaka Ohkouchi, Naoto Kosuga, Ikuya Shiromizu, Tomokazu Matsusue, Ichiro Yamamoto, Miwa Matsumoto, Takafumi Mukaihira
Publikováno v:
Chemical and Pharmaceutical Bulletin. 55:317-323
In the course of development of factor Xa (FXa) inhibitors, we have found unique compounds containing an N,O- and an N,N-spiro acetal structure. It appeared that the difference in overall conformation due to the N,X-spiro acetal structure might be im
Autor:
Masatsugu Kamiya, Hidemistu Nishida, Mikihiko Shinozaki, Hidemi Ishii, Tamami Ohno, Tomokazu Matsusue, Yukiko Yatagai, Miwa Matsumoto, Kiyoshi Mizuguchi, Misao Kurokawa, Yoshitaka Hosaka
Publikováno v:
European Journal of Pharmacology. 529:164-171
Factor Xa plays an important role in blood coagulation and is widely regarded as an attractive target for antithrombotic drug development. M55551 and M55165 (1-arylsulfonyl-3-piperazinone derivatives) are novel synthetic factor Xa inhibitors. In vitr
Autor:
Fumihiko Saitoh, Hidenori Mochizuki, Atsushi Okamoto, Hidemitsu Nishida, Yoshitaka Hosaka, Hiroyasu Shimada, Tomokazu Matsusue, Yutaka Miyazaki, Takafumi Mukaihira, Kazuhiro Suzuki, Masashi Mizuno, Miwa Matsumoto, Shuhei Ohnishi
Publikováno v:
Chemical and Pharmaceutical Bulletin. 52:459-462
Compounds containing an ethylenediamine structure in place of the piperazine ring of M55113 (1) and M55551 (2) were synthesized to investigate the effects of a piperazine moiety and evaluated for activity as factor Xa (FXa) inhibitors. Most such comp
Autor:
Hidemitsu Nishida, Yoshitaka Hosaka, Harada Kousuke, Manabu Itoh, Aki Muraoka, Hidenori Mochizuki, Tomokazu Matsusue, Fumihiko Saitoh, Miwa Matsumoto, Miyuki Fukui, Shuhei Ohnishi, Atsushi Okamoto, Takafumi Mukaihira, Yutaka Miyazaki
Publikováno v:
Chemical and Pharmaceutical Bulletin. 50:1187-1194
Intravascular clot formation is an important event in a number of cardiovascular diseases. The prevention of blood coagulation has become a major target for new therapeutic agents. Factor Xa (FXa) is a trypsin-like serine protease that plays a key ro
Autor:
Yutaka Miyazaki, Hidemitsu Nishida, Masayuki Ohashi, Hidenori Mochizuki, Yoshihiro Kitamura, Tomokazu Matsusue, Yoshitaka Hosaka, Atsushi Okamoto, Shuhei Ohnishi
Publikováno v:
Chemical and Pharmaceutical Bulletin. 49:1237-1244
Intravascular clot formation is an important factor in a number of cardiovascular diseases. Therefore, the prevention of blood coagulation has become a major target for new therapeutic agents. One attractive approach is the inhibition of factor Xa (F
Autor:
Keisuke Sugihara, Hideaki Morishita, Toshinori Kanamori, Hideaki Umeyama, Jiro Hirose, Mitsuko Isaji, Tomokazu Matsusue, Toshihisa Miura, Yoshifumi Horisawa, Toru Yamakawa, Atsushi Nii
Publikováno v:
The Journal of Biochemistry. 115:1107-1112
The second domain (R-020) of human urinary trypsin inhibitor (UTI) exerts similar inhibitory activities on trypsin, alpha-chymotrypsin, leukocyte elastase, and plasmin to those of UTI itself, and additionally inhibits coagulation factor Xa (FXa) and
Autor:
Hidemitsu Nishida, Yutaka Miyazaki, Masayuki Ohashi, Atsushi Okamoto, Yoshitaka Hosaka, Yoshihiro Kitamura, Hidenori Mochizuki, Tomokazu Matsusue, Shuhei Ohnishi
Publikováno v:
ChemInform. 33
Intravascular clot formation is an important factor in a number of cardiovascular diseases. Therefore, the prevention of blood coagulation has become a major target for new therapeutic agents. One attractive approach is the inhibition of factor Xa (F
Autor:
Junken Aoki, Nozomu Kono, Hiroyuki Sato, Hiroyuki Arai, Etsuo Niki, Tomokazu Matsusue, Yasukazu Yoshida, Takao Inoue, Hiroyuki Itabe
Publikováno v:
The Journal of biological chemistry. 283(3)
Membrane phospholipids are susceptible to oxidation, which is involved in various pathological processes such as inflammation, atherogenesis, neurodegeneration, and aging. One enzyme that may help to remove oxidized phospholipids from cells is intrac
Autor:
Hidemitsu Nishida, Fumihiko Saitoh, Ichiro Yamamoto, Takafumi Mukaihira, Naoto Kosuga, Miwa Matsumoto, Yoshitaka Hosaka, Munetaka Ohkouchi, Ikuya Shiromizu, Tomokazu Matsusue
Publikováno v:
ChemInform. 38